Biogen to buy early-stage potential Alzheimer’s, Parkinson’s treatment from Pfizer

Biogen to buy early-stage potential Alzheimer’s, Parkinson’s treatment from Pfizer
Biogen Inc said on Monday it has agreed to buy an early-stage experimental treatment from Pfizer Inc that it aims to test in patients with Alzheimer's and Parkinson's disease. ... read more
Source: Reuters HealthPublished on 2020-01-13